Elevated calcium and activation of trypsinogen in rat pancreatic acini

Gut

Volumn 41, Issue 3, 1997, Pages 339-343

  Frick, T W ^b,c   Fernandez del Castillo C ^a   Bimmler, D ^b   Warshaw, A L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Acute pancreatitis; Hypercalcaemia; Pancreatitis pathogenesis; Serine proteases

Indexed keywords

AMYLASE; CALCIUM CHLORIDE; CARBACHOL; CERULETIDE; N(G) METHYLARGININE; SERINE PROTEINASE; TRYPSINOGEN; VERAPAMIL;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HYPERCALCEMIA; MALE; NONHUMAN; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0030804477     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.3.339     Document Type: Article

References (26)

1. Ward JB, Peterson OH, Jenkins SA, Sutton R. Is an elevated concentration of acinar cytosolic free ionized calcium the trigger for acute pancreatitis? Lancet 1995; 346: 1016-9.
2. Fernàndez-del Castillo C, Harringer W, Warshaw AL, Vlahakes GJ, Koski G, Zaslavsky AM, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382-7.
3. Frick TW, Speiser DE, Bimmler D, Largiadèr F. Drug-induced acute pancreatitis; further criticism. Dig Dis 1993; 11: 113-32.
4. Frick TW, Fryd DS, Sutherland DER, Goodale RL, Simmons RL, Najarian JS. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987; 154: 487-9.
5. Mithöfer K, Fernàndez-del Castillo C, Frick TW, Lewandrowski KB, Rattner DW, Warshaw AL. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 1995; 109: 239-46.
6. Frick TW, Hailemariam S, Heitz PU, Largiadèr F, Goodale RL. Acute hypercalcaemia induces acinar cell necrosis and intraductal precipitates in the pancreas of cat and guinea pig. Gastroenterology 1990; 98: 1675-81.
7. Frick TW, Wiegand D, Bimmler D, Fernández-del Castillo C, Rattner DW, Warshaw AL. A rat model to study hypercalcemia-induced pancreatitis. Int J Pancreatol 1994;, 15: 91-6.
8. Frick TW, Mithöfer K, Fernàndez-del Castillo C, Rattner DW, Warshaw AL. Hypercalcemia causes acute pancreatitits by pancreatic secretory block, intracellular zymogen accumulation and acinar cell injury. Am J Surg 1995; 169: 167-72.
9. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988; 111: 195-203.
10. Mithöfer K, Fernàndez-del Castillo C, Mandavilli U, Rattner DW, Warshaw AL. Quantitative assay of trypsinogen by measurement of cleaved activation peptide after activation with enterokinase. Anal Biochem 1995; 230: 348-50.
11. Bruzzone R, Halban PA, Gjinovci A, Trimble ER. A new, rapid, method for preparation of dispersed pancreatic acini. Biochem J 1985; 226: 621-4.
12. Layer P, Hotz J, Cherian L, Goebell H. In vitro stimulation of pancreatic enzyme discharge by elevated extracellular calcium concentrations. Gut 1987; 28: 1215-20.
13. Rinderknecht H. Pancreatic secretory enzymes. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The exocrine pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993: 219-51.
14. Gorelick FS, Matovcik LM. Lysosomal enzymes and pancreatitis [editorial]. Gastroenterology 1995; 109: 620-5.
15. Colomb E, Figarella C. Comparative studies on the mechanism of activation of the two human trypsinogens. Biochim Biophys Acta 1979; 571: 343-51.
16. Haverbeck BJ, Dyce B, Bundy H, Edmondson HA. Trypsin, trypsinogen and trypsin inhibitor in human pancreatic juice. Am J Med 1960; 29: 424-33.
17. Kassel B, Kay J. Zymogens of proteolytic enzymes. Science 1973; 180: 1022-7.
18. Krims PE, Pandol SJ. Free cytosolic calcium and secretagogue-stimulated initial pancreatic exocrine secretion. Pancreas 1988; 3: 383-90.
19. Leach SD, Modlin IM, Scheele GA, Gorelick FS. Intracellular activation of digestive zymogens in rat pancreatic acini. J Clin Invest 1991; 87: 362-6.
20. Bruzzone R. The molecular basis of enzyme secretion. Gastroenterology 1990; 99: 1157-76.
21. Gukovskaya A, Pandol S. Nitric oxide production regulates cGMP formation and calcium influx in pancreatic acinar cells. Am J Physiol 1994; 266: G350-6.
22. Slimak GG, Stark HA, Egan JJ, Jensen RT, Gardner JD. Effect of verapamil on the cyclic AMP-mediated pathway for amylase secretion in rat pancreatic acini. Pancreas 1993; 8: 212-9.
23. Petersen OH, Gallacher DV. Electrophysiology of pancreatic and salivary acinar cells. Annu Rev Physiol 1988; 50: 65-81.
24. 2+-channel blockers" on exocrine pancreatic secretion by isolated rat acini. Res Exp Med 1988; 188: 255-65.
25. Frick TW, Mithöfer K, Fernández-del Castillo C, Rattner DW, Warshaw AL. Influence of verapamil and nifedipine on cerulein, secretin and A23187 stimulated rat pancreatic acini: effect of elevated extracellular calcium. Digestion 1995; 56: 285-6.
26. Gardner JD, Jensen RT. Receptors for secretagogues on pancreatic acinar cells. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The exocrine pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993: 151-66.